A novel FOXM1 isoform, FOXM1D, promotes epithelial–mesenchymal transition and metastasis through ROCKs activation in colorectal cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A novel FOXM1 isoform, FOXM1D, promotes epithelial–mesenchymal transition and metastasis through ROCKs activation in colorectal cancer
Authors
Keywords
-
Journal
ONCOGENE
Volume 36, Issue 6, Pages 807-819
Publisher
Springer Nature
Online
2016-07-11
DOI
10.1038/onc.2016.249
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cellular signaling pathways implicated in metastasis of colorectal cancer and the associated targeted agents
- (2015) Xuan Liu et al. Future Oncology
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β–dependent cancer metastasis
- (2014) Jianfei Xue et al. JOURNAL OF CLINICAL INVESTIGATION
- DLC1-dependent parathyroid hormone–like hormone inhibition suppresses breast cancer bone metastasis
- (2014) Yufeng Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- FOXM1 promotes the epithelial to mesenchymal transition by stimulating the transcription of Slug in human breast cancer
- (2013) Chao Yang et al. CANCER LETTERS
- C-terminus-deleted FoxM1 is expressed in cancer cell lines and induces chromosome instability
- (2013) Young Hwa Kim et al. CARCINOGENESIS
- The enforced expression of c-Myc in pig fibroblasts triggers mesenchymal-epithelial transition (MET) via F-actin reorganization and RhoA/Rock pathway inactivation
- (2013) Jun-Wen Shi et al. CELL CYCLE
- FOX(M1) News--It Is Cancer
- (2013) M. Halasi et al. MOLECULAR CANCER THERAPEUTICS
- Misregulation of Pre-mRNA Alternative Splicing in Cancer
- (2013) J. Zhang et al. Cancer Discovery
- Rho-associated kinases in tumorigenesis: re-considering ROCK inhibition for cancer therapy
- (2012) Nicola Rath et al. EMBO REPORTS
- Regulation of ROCK Activity in Cancer
- (2012) Marie Morgan-Fisher et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- FOXM1 coming of age: time for translation into clinical benefits?
- (2012) Muy-Teck Teh Frontiers in Oncology
- P-Cadherin Promotes Liver Metastasis and Is Associated with Poor Prognosis in Colon Cancer
- (2011) Lichao Sun et al. AMERICAN JOURNAL OF PATHOLOGY
- FoxM1 Promotes β-Catenin Nuclear Localization and Controls Wnt Target-Gene Expression and Glioma Tumorigenesis
- (2011) Nu Zhang et al. CANCER CELL
- FoxM1: A Master Regulator of Tumor Metastasis
- (2011) P. Raychaudhuri et al. CANCER RESEARCH
- A novel mode of FoxM1 regulation: Positive auto-regulatory loop
- (2011) Marianna Halasi et al. CELL CYCLE
- Multiple faces of FoxM1 transcription factor
- (2011) Tanya V. Kalin et al. CELL CYCLE
- Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells
- (2011) Bin Bao et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- A Perspective on Cancer Cell Metastasis
- (2011) C. L. Chaffer et al. SCIENCE
- Deregulation of FoxM1b leads to tumour metastasis
- (2010) Hyun Jung Park et al. EMBO Molecular Medicine
- FoxM1B Transcriptionally Regulates Vascular Endothelial Growth Factor Expression and Promotes the Angiogenesis and Growth of Glioma Cells
- (2008) Yujian Zhang et al. CANCER RESEARCH
- Fifty years of coiled-coils and α-helical bundles: A close relationship between sequence and structure
- (2008) David A.D. Parry et al. JOURNAL OF STRUCTURAL BIOLOGY
- Characterization of HCT116 Human Colon Cancer Cells in an Orthotopic Model
- (2007) Ashwani Rajput et al. JOURNAL OF SURGICAL RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started